Second Messengers of Insulin Action
Overview
Authors
Affiliations
Despite significant advances in past years on the chemistry and biology of insulin and its receptor, the molecular events that couple the insulin-receptor interaction to the regulation of cellular metabolism remain uncertain. Progress in this area has been complicated by the pleiotropic nature of the actions of insulin. These most likely involve a complex network of pathways resulting in the coordination of mechanistically distinct cellular effects. Because the well-recognized mechanisms of signal transduction (i.e., cyclic nucleotides, ion channels) appear not to be central to insulin action, investigators have searched for a novel second-messenger system. A low-molecular-weight substance has been identified that mimics certain actions of insulin on metabolic enzymes. This substance has an inositol glycan structure, and is produced by the insulin-sensitive hydrolysis of a glycosylphosphatidylinositol in the plasma membrane. This hydrolysis reaction, which is catalyzed by a specific phospholipase C, also results in the production of a structurally distinct diacylglycerol that may selectively regulate one or more of the protein kinases C. The glycosyl-phosphatidylinositol precursor for the inositol glycan enzyme modulator is structurally analogous to the recently described glycosyl-phosphatidylinositol membrane protein anchor. Preliminary studies suggest that a subset of proteins anchored in this fashion may be released from cells by a similar insulin-sensitive phospholipase-catalyzed reaction. Future efforts will focus on the precise role of the metabolism of glycosyl phosphatidylinositols in insulin action.
Caruana R, Zizzo M, Caldara G, Montalbano F, Fasciano S, Arena D Int J Mol Sci. 2024; 25(7).
PMID: 38612662 PMC: 11012041. DOI: 10.3390/ijms25073852.
Muller G, Muller T Biomolecules. 2023; 13(5).
PMID: 37238725 PMC: 10216265. DOI: 10.3390/biom13050855.
Muller G, Muller T Int J Mol Sci. 2022; 23(13).
PMID: 35806423 PMC: 9267055. DOI: 10.3390/ijms23137418.
Mashayekh-Amiri S, Mohammad-Alizadeh-Charandabi S, Abdolalipour S, Mirghafourvand M Diabetol Metab Syndr. 2022; 14(1):93.
PMID: 35794663 PMC: 9258131. DOI: 10.1186/s13098-022-00862-5.
Zarezadeh M, Dehghani A, Faghfouri A, Radkhah N, Naemi Kermanshahi M, Hamedi Kalajahi F Obes Sci Pract. 2022; 8(3):387-397.
PMID: 35664247 PMC: 9159559. DOI: 10.1002/osp4.569.